New Jersey Drug Utilization Review Board Agenda January 2026
Gainwell Technologies Continues PA Reporting Engagement
Trusted by teams at
Description
The New Jersey Drug Utilization Review Board received a 3rd Quarter 2025 prior authorization report prepared by Gainwell Technologies and NJ managed care organizations, reflecting Gainwell’s ongoing role in pharmacy utilization reporting. The engagement supports oversight of fee-for-service and MCO pharmacy prior authorization activity across the state health programs.
Contract Details
Vendor
GAINWELL TECHNOLOGIES
Agency
New Jersey Department of Human Services, NJ
Contract Type
PROFESSIONAL_SERVICES
Document Date
January 28, 2026
Contract Term
3rd Quarter 2025 reporting period
Renewal Info
Report is part of recurring quarterly prior authorization reporting services; no explicit renewal or amendment terms are stated in the agenda.
More from GAINWELL TECHNOLOGIES
Related Contracts
Cherokee County Board of Commissioners Meeting Agenda 2026-05-18
PENDINGNew Jersey Drug Utilization Review Board Agenda April 2026
ONGOINGDepartment of Health Care Policy & Financing Case Management Agency Director Meeting Report February 2026
ONGOINGIndiana Family and Social Services Administration Medicaid Oversight Committee Report Jan 2026
ONGOINGshawano-county-community-services-advisory-committee-meeting-agenda_dc7.pdf
ongoingWant to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.